Cryo Cell International (CCEL) Payables (2010 - 2026)

Cryo Cell International has disclosed Payables across 17 years of filings, most recently posting $3.5 million for Q1 2026.

• In Q1 2026, Payables rose 19.48% year-over-year to $3.5 million; the TTM figure through Feb 2026 stood at $3.5 million (up 19.48% YoY), while the FY2025 annual figure was $3.1 million, up 48.8% from the prior year.
• Payables grew to $3.5 million in Q1 2026, from $3.1 million in the prior quarter.
• Over the last five years, Payables for CCEL reached as high as $9.6 million in Q3 2022 and fell as low as $657561.0 in Q4 2023.
• The 5-year median for Payables is $2.8 million (2025), against an average of $3.0 million.
• Annual changes were most pronounced in 2023 — Payables sank 69.35% — and 2024, when it soared 212.18%.
• A 5-year view of Payables shows it stood at $1.8 million in 2022, then slumped by 62.55% to $657561.0 in 2023, then soared by 212.18% to $2.1 million in 2024, then soared by 48.8% to $3.1 million in 2025, then grew by 14.35% to $3.5 million in 2026.
• According to Business Quant data, Payables over the past three periods registered $3.5 million, $3.1 million, and $2.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.